Summary
Glutaric aciduria type I (GA I), a cerebral organic acidaemia with the potential for severe neurological consequences, can now be detected by tandem mass spectrometry newborn screening. Early detection with implementation of careful management strategies appears to lessen the likelihood of neurological damage. We assessed the outcome in all 10 GA I patients detected in New South Wales during the last decade. Three patients were detected clinically and 7 by newborn screening. Diagnosis was confirmed by detection of significantly elevated urinary 3-hydroxybutyrate and glutarate in urine, isolated elevation of glutarylcarnitine in plasma, typical clinical and MRI findings in several, and mutation analysis or enzyme analysis on cultured skin fibroblasts in 4 cases. The birth frequency was 1:90 000. Following diagnosis, treatment was initiated in all children with oral carnitine (100 mg/kg per day) and a low-protein diet supplemented with a lysine-free, low-tryptophan amino acid formula. Disability was assessed in fields of motor, cognitive and speech development and scored according to Kyllerman. Clinically diagnosed patients were all symptomatic, with severity scores (out of 9) of 3, 5 and 9. Six of seven patients detected by newborn screening are asymptomatic, 4 being aged 2–6 years. One patient had a severe decompensation at 7 months, despite full management advice and treatment, and later died. Our data support previous findings that early diagnosis reduces neurological complications, but show that even with early diagnosis and careful management severe complications may ensue in some.
Similar content being viewed by others
References
Christensen E (1983) Improved assay of glutaryl CoA dehydrogenase in cultured cells and liver. Clin Chim Acta 129: 91–97.
Goodman SI, Freeman FE (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2195–2204.
Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: a ‘new’ disorder of amino acid metabolism. Biochem Med 12: 12–21.
Kölker S, Garbade SF, Greenberg CR, et al (2006) Natural history, outcome and therapeutic efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59: 840–847.
Kölker S, Christensen E, Leonard JV, et al (2007a) Guideline for the diagnosis and management. J Inherit Metab Dis 30: 5–22.
Kölker S, Garbade SF, Boy N, et al (2007b) Decline of acute encephalopathic crises in children with glutaryl -CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62: 357–363.
Kyllerman M, Skjeldal O, Christensen E, et al (2004) Long-term follow up, neurological outcome and survival rate in 28 Nordic patients with glutaric acidemia type 1. Eur J Paediatr Neurol 8: 121–129.
Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT (2004) Glutaric aciduria type I: Outcome in the Republic of Ireland. J Inherit Metab Dis 27: 917–920.
Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type 1 glutaric aciduria, part I: natural history of 77 patients. Am J Med Gen semin Med Genet 121: 38–52.
Twomey EL, Naughten ER, Donoghue VB, Ryan S. (2003). Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33: 823–830.
Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348: 2304–2312.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Georg Hoffman
Competing interests: None declared
References to electronic databases: Glutaric aciduria type I (synonym glutaryl-CoA dehydrogenase deficiency): OMIM # 231670. Glutaryl-CoA dehydrogenase: EC 1.3.99.7.
Rights and permissions
About this article
Cite this article
Bijarnia, S., Wiley, V., Carpenter, K. et al. Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31, 503–507 (2008). https://doi.org/10.1007/s10545-008-0912-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0912-z